{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:26:08Z","timestamp":1789014368295,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T00:00:00Z","timestamp":1406505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00125-014-3332-7","type":"journal-article","created":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T22:14:21Z","timestamp":1406412861000},"page":"2201-2207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18\u00a0year follow-up study"],"prefix":"10.1007","volume":"57","author":[{"given":"Jakob A.","family":"\u00d8stergaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hovind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte B.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Henrik","family":"Parving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Flyvbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels K.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,28]]},"reference":[{"key":"3332_CR1","unstructured":"U.S. Renal Data System (2013) USRDS 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. Available from www.usrds.org\/2013\/pdf\/v2_ch1_13.pdf . Accessed 27 June 2014"},{"key":"3332_CR2","unstructured":"European Renal Association, European Dialysis and Transplant Association (2011) ERA\u2013EDTA Registry: annual report 2011. Available from www.era-edta-reg.org\/files\/annualreports\/pdf\/AnnRep2011.pdf . Accessed 27 June 2014"},{"key":"3332_CR3","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.2337\/diabetes.53.6.1570","volume":"53","author":"TK Hansen","year":"2004","unstructured":"Hansen TK, Tarnow L, Thiel S et al (2004) Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 53:1570\u20131576","journal-title":"Diabetes"},{"key":"3332_CR4","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1210\/jc.2003-030742","volume":"88","author":"TK Hansen","year":"2003","unstructured":"Hansen TK, Thiel S, Knudsen ST et al (2003) Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J Clin Endocrinol Metab 88:4857\u20134861","journal-title":"J Clin Endocrinol Metab"},{"key":"3332_CR5","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2337\/diabetes.54.5.1523","volume":"54","author":"P Hovind","year":"2005","unstructured":"Hovind P, Hansen TK, Tarnow L et al (2005) Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study. Diabetes 54:1523\u20131527","journal-title":"Diabetes"},{"key":"3332_CR6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00125-004-1594-1","volume":"48","author":"M Saraheimo","year":"2004","unstructured":"Saraheimo M, Forsblom C, Hansen TK et al (2004) Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia 48:198\u2013202","journal-title":"Diabetologia"},{"key":"3332_CR7","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00125-007-0686-0","volume":"50","author":"J \u00d8stergaard","year":"2007","unstructured":"\u00d8stergaard J, Thiel S, Gadjeva M, Hansen TK, Rasch R, Flyvbjerg A (2007) Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice. Diabetologia 50:1541\u20131549","journal-title":"Diabetologia"},{"key":"3332_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/678381","volume":"2012","author":"JA \u00d8stergaard","year":"2012","unstructured":"\u00d8stergaard JA, Bjerre M, Ramachandrarao SP et al (2012) Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes model. Exp Diabetes Res 2012:1\u20139","journal-title":"Exp Diabetes Res"},{"key":"3332_CR9","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.1074\/jbc.M111.301044","volume":"287","author":"RM Zacho","year":"2012","unstructured":"Zacho RM, Jensen L, Terp R, Jensenius JC, Thiel S (2012) Studies of the pattern recognition molecule H-ficolin: specificity and purification. J Biol Chem 287:8071\u20138081","journal-title":"J Biol Chem"},{"key":"3332_CR10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/BF03401659","volume":"2","author":"JA Acosta","year":"1996","unstructured":"Acosta JA, Benzaquen LR, Goldstein DJ, Tosteson MT, Halperin JA (1996) The transient pore formed by homologous terminal complement complexes functions as a bidirectional route for the transport of autocrine and paracrine signals across human cell membranes. Mol Med 2:755\u2013765","journal-title":"Mol Med"},{"key":"3332_CR11","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1172\/JCI113637","volume":"82","author":"JA Halperin","year":"1988","unstructured":"Halperin JA, Nicholson-Weller A, Brugnara C, Tosteson DC (1988) Complement induces a transient increase in membrane permeability in unlysed erythrocytes. J Clin Invest 82:594\u2013600","journal-title":"J Clin Invest"},{"key":"3332_CR12","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI116418","volume":"91","author":"JA Halperin","year":"1993","unstructured":"Halperin JA, Taratuska A, Nicholson-Weller A (1993) Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells. J Clin Invest 91:1974\u20131978","journal-title":"J Clin Invest"},{"key":"3332_CR13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood.V81.1.200.200","volume":"81","author":"JA Halperin","year":"1993","unstructured":"Halperin JA, Taratuska A, Rynkiewicz M, Nicholson-Weller A (1993) Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex (C5b-9). Blood 81:200\u2013205","journal-title":"Blood"},{"key":"3332_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1385\/IR:31:1:37","volume":"31","author":"M Fosbrink","year":"2005","unstructured":"Fosbrink M, Niculescu F, Rus H (2005) The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription. Immunol Res 31:37\u201346","journal-title":"Immunol Res"},{"key":"3332_CR15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1084\/jem.179.3.985","volume":"179","author":"LR Benzaquen","year":"1994","unstructured":"Benzaquen LR, Nicholson-Weller A, Halperin JA (1994) Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med 179:985\u2013992","journal-title":"J Exp Med"},{"key":"3332_CR16","first-page":"51","volume":"2","author":"C Wagner","year":"1994","unstructured":"Wagner C, Braunger M, Beer M, Rother K, Hansch GM (1994) Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex. Exp Nephrol 2:51\u201356","journal-title":"Exp Nephrol"},{"key":"3332_CR17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/bmj.38070.450891.FE","volume":"328","author":"P Hovind","year":"2004","unstructured":"Hovind P, Tarnow L, Rossing P et al (2004) Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 328:1105","journal-title":"BMJ"},{"key":"3332_CR18","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/diacare.26.4.1258","volume":"26","author":"P Hovind","year":"2003","unstructured":"Hovind P, Tarnow L, Rossing K et al (2003) Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 26:1258\u20131264","journal-title":"Diabetes Care"},{"key":"3332_CR19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-3038.2010.01104.x","volume":"22","author":"S Sallenbach","year":"2011","unstructured":"Sallenbach S, Thiel S, Aebi C et al (2011) Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr Allergy Immunol 22:424\u2013430","journal-title":"Pediatr Allergy Immunol"},{"key":"3332_CR20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","volume":"345","author":"HH Parving","year":"2001","unstructured":"Parving HH, Lehnert H, Brochner-Mortensen J et al (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870\u2013878","journal-title":"N Engl J Med"},{"key":"3332_CR21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.1994.03510280037029","volume":"271","author":"G Viberti","year":"1994","unstructured":"Viberti G, Mogensen CE, Groop LC, Pauls JF (1994) Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA 271:275\u2013279","journal-title":"JAMA"},{"key":"3332_CR22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/00365518509155256","volume":"45","author":"B Feldt-Rasmussen","year":"1985","unstructured":"Feldt-Rasmussen B, Dinesen B, Deckert M (1985) Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45:539\u2013544","journal-title":"Scand J Clin Lab Invest"},{"key":"3332_CR23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2337\/diab.42.5.715","volume":"42","author":"P Rossing","year":"1993","unstructured":"Rossing P, Hommel E, Smidt UM, Parving HH (1993) Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 42:715\u2013719","journal-title":"Diabetes"},{"key":"3332_CR24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/clinchem\/20.4.415","volume":"20","author":"J Lizana","year":"1974","unstructured":"Lizana J, Hellsing K (1974) Polymer enhancement of automated immunological nephelometric analysis, as illustrated by determination of urinary albumin. Clin Chem 20:415\u2013420","journal-title":"Clin Chem"},{"key":"3332_CR25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/00365517009049206","volume":"26","author":"DW Miles","year":"1970","unstructured":"Miles DW, Mogensen CE, Gundersen HJ (1970) Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest 26:5\u201311","journal-title":"Scand J Clin Lab Invest"},{"key":"3332_CR26","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/IAI.73.2.1052-1060.2005","volume":"73","author":"A Krarup","year":"2005","unstructured":"Krarup A, Sorensen UB, Matsushita M, Jensenius JC, Thiel S (2005) Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun 73:1052\u20131060","journal-title":"Infect Immun"},{"key":"3332_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137\u2013147","journal-title":"Ann Intern Med"},{"key":"3332_CR28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/dmrr.1079","volume":"26","author":"J Fortpied","year":"2010","unstructured":"Fortpied J, Vertommen D, Van Schaftingen E (2010) Binding of mannose-binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetes. Diabetes Metab Res Rev 26:254\u2013260","journal-title":"Diabetes Metab Res Rev"},{"key":"3332_CR29","first-page":"18539","volume":"10","author":"WX Fan","year":"2011","unstructured":"Fan WX, Huang SM, Liu F et al (2011) Activation of the lectin complement pathway on human renal glomerular endothelial cells triggered by high glucose and mannose-binding lectin. Afr J Biotechnol 10:18539\u201318549","journal-title":"Afr J Biotechnol"},{"key":"3332_CR30","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1073\/pnas.97.10.5450","volume":"97","author":"J Acosta","year":"2000","unstructured":"Acosta J, Hettinga J, Fluckiger R et al (2000) Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci U S A 97:5450\u20135455","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3332_CR31","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/diabetes.53.10.2653","volume":"53","author":"X Qin","year":"2004","unstructured":"Qin X, Goldfine A, Krumrei N et al (2004) Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes. Diabetes 53:2653\u20132661","journal-title":"Diabetes"},{"key":"3332_CR32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nm0395-237","volume":"1","author":"R Malhotra","year":"1995","unstructured":"Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1:237\u2013243","journal-title":"Nat Med"},{"key":"3332_CR33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.7326\/0003-4819-101-4-527","volume":"101","author":"M Brownlee","year":"1984","unstructured":"Brownlee M, Vlassara H, Cerami A (1984) Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101:527\u2013537","journal-title":"Ann Intern Med"},{"key":"3332_CR34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/j.ajkd.2004.04.027","volume":"44","author":"N Uesugi","year":"2004","unstructured":"Uesugi N, Sakata N, Nangaku M et al (2004) Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation. Am J Kidney Dis 44:224\u2013238","journal-title":"Am J Kidney Dis"},{"key":"3332_CR35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-3083.2007.02003.x","volume":"66","author":"DC Kilpatrick","year":"2007","unstructured":"Kilpatrick DC, Downing I, MacDonald SL, Turner ML (2007) MBL really binds to healthy human cells! Scand J Immunol 66:599\u2013600","journal-title":"Scand J Immunol"},{"key":"3332_CR36","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.4049\/jimmunol.156.9.3455","volume":"156","author":"T Takabayashi","year":"1996","unstructured":"Takabayashi T, Vannier E, Clark BD et al (1996) A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. J Immunol 156:3455\u20133460","journal-title":"J Immunol"},{"key":"3332_CR37","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.1300489","volume":"191","author":"F Laudisi","year":"2013","unstructured":"Laudisi F, Spreafico R, Evrard M et al (2013) Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1beta release. J Immunol 191:1006\u20131010","journal-title":"J Immunol"},{"key":"3332_CR38","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1242\/jcs.124388","volume":"126","author":"K Triantafilou","year":"2013","unstructured":"Triantafilou K, Hughes TR, Triantafilou M, Morgan BP (2013) The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J Cell Sci 126:2903\u20132913","journal-title":"J Cell Sci"},{"key":"3332_CR39","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1182\/blood-2013-05-502229","volume":"122","author":"E Asgari","year":"2013","unstructured":"Asgari E, Le Friec G, Yamamoto H et al (2013) C3a modulates IL-1beta secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood 122:3473\u20133481","journal-title":"Blood"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-014-3332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-014-3332-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-014-3332-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T14:17:07Z","timestamp":1689430627000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-014-3332-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,28]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["3332"],"URL":"https:\/\/doi.org\/10.1007\/s00125-014-3332-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,28]]}}}